Expansion Capacity of Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease: An Intravascular Ultrasound Guided Study
Автор: Mohamed Mahrous Ali, Basheer Hafez Mohamed, Metwally Hasan El Emary,Ashraf Ahmed Abd Al Mageed
Журнал: Cardiometry @cardiometry
Статья в выпуске: 19, 2021 года.
Бесплатный доступ
Aims: The aim of this study was to assess the expansion capacity of current commercially available Drug Eluting Stents (DES) with nominal diameters of 3.5-4.0mm in patients with Left Main disease. Materials and Methods: This study was conducted on 50 Patients who underwent percutaneous coronary intervention (PCI)for Left Main disease at Benha university hospitals and National Heart Institute. PCI was done with Drug Eluting Stents (DES) with large diameters of 3.5-4mm and post dilatation was done with non-compliant (NC) balloons with diameters of 4.5- 5mm. Intravascular ultrasound (IVUS) was used to measure maximal stent diameter and area. Results: Three commercially available DESs were used in our study; XIENCE Xpeditionᵀᴹ, Ultimasterᵀᴹ and Onyxᵀᴹ. Maximal stent diameter was 4.5±0.3mm and diameter expansion index was 0.96±0.05. Maximal stent area was 14.67±2.06mm² and area expansion index was 0.86±0.07mm². On IVUS images, significantly more calcification< 90 ̊ was detected in the group with expansion index - 0.85 (68.4 percent versus 25.8%, P=0.003) compared to the group with expansion index - 0.85. We found that DESs with diameters of 3.5-4.0mm can be expanded up to diameter of 5.3mm after post-dilation. No complications were reported in the studied patients, including perforation or stent fracture. Conclusion: Current DESs with nominal diameters of 3.5-4.0mm can be safely and effectively over-expanded to reach the predicted diameters in the left main, but the presence of calcification -90 may affect the achievement of the predicted area.
Left Main, Intravascular Ultrasound, Expansion Capacity, Drug Eluting Stents.
Короткий адрес: https://sciup.org/148320560
IDR: 148320560 | DOI: 10.18137/cardiometry.2021.19.117122
Список литературы Expansion Capacity of Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease: An Intravascular Ultrasound Guided Study
- Lee PH, Ahn JM, Chang M, et al. Left main coronary artery disease: Secular trends in patient characteristics, treatments, and outcomes. J Am Coll Cardiol 2016; 68:1233–1246.
- Park SJ, Hong MK, Lee CW, et al. Elective stenting of unprotected left main coronary artery stenosis: Effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 2001; 38: 1054–1060.
- Tan WA, Tamai H, Park SJ, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 2001; 104: 1609–1614.
- Black A, Cortina R, Bossi I, et al. Unprotected left main coronary artery stenting: Correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 2001; 37: 832–838.
- Giacoppo D, et al. Percutaneous coronary intervention vs coronaryartery bypass grafting in patients with left main coronary artery stenosis: A systematic review and meta-analysis. JAMA Cardiol 2017;2:1079–1088.
- Franz-Josef, Neumann Miguel, Sousa-Uva et al 2018. ESC/EACTS Guidelines on myocardial revascu122 larization. European Heart Journal, Volume 40, Issue 2, 07 January 2019, Pages 87–165.
- Ye Y, Qian H, Yang M, Zhu X, Gan T, Zhang S, Zeng Y. Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study. J Int Med Res. 2017 Aug;45(4):1406-1416. doi: 10.1177/0300060517708515. Epub 2017 Jun 12. PMID: 28606023; PMCID: PMC5625525.
- Foin N, Alegria E, Sen S, et al. Importance of knowing stent design threshold diameters and post-dilatation capacities to optimize stent selection and prevent stent overexpansion/incomplete apposition during PCI. Int J Cardiol 2013; 166: 755–758.
- Ng J, Foin N, Ang HY, et al. Overexpansion capacity and stent design model: an update with contemporary des platforms.Int J Cardiol 2016; 221: 171–179.